Lilly’s Foundayo Pill Matched Insulin on Heart Safety in Lancet Trial, but Its Lower Death Rate Needs Caution

Lilly’s Foundayo pill met a heart-safety test against insulin in a Lancet trial. Fewer deaths were seen, but that result is secondary.

Have A Referral?